A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell lymphoma

Omer N. Koç, Charles Redfern, Peter H. Wiernik, Fred Rosenfelt, Jane N. Winter, William D. Carter, Dan P. Gold, Morgan E. Stewart, Richard G. Ghalie, John F. Bender

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences